Regorafenib- A feasible option as third-line therapy of recurrent glioblastoma?

• Alice Dauth,
• Harald Krenzlin,
• Felipa Lange,
• Florian Ringel,
• Naureen Keric

Affiliations

Alice Dauth

University Medical Center of Johannes Gutenberg-University , Mainz, Germany

Harald Krenzlin

University Medical Center of Johannes Gutenberg-University , Mainz, Germany

Felipa Lange

University Medical Center of Johannes Gutenberg-University , Mainz, Germany

Florian Ringel

University Medical Center of Johannes Gutenberg-University , Mainz, Germany

Naureen Keric

University Medical Center of Johannes Gutenberg-University , Mainz, Germany